secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K
Filed at:   2024-10-30T23:59:59+00:00
Accession:  0001606498-24-000082
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO Joseph Woody retires; CFO Michael Greiner named interim CEO; Warren Machan interim CFO
--------------------------------------------------------------------------------

- Joseph Woody retired as CEO and board member effective Oct 28, 2024; will consult through Apr 30, 2025 at $84,618/month.
- Michael Greiner (SVP/CFO/CTO) appointed interim CEO; receives $600k salary, $83k/month stipend, and $1M RSU grant.
- Warren Machan (former SVP Business Strategy) appointed interim CFO; compensation not yet determined.
- Board will conduct a search for permanent CEO; Greiner is leading candidate but will evaluate other candidates.
- Company reported Q3 2024 financial results via press release on Oct 30; specific figures not included in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649824000082/0001606498-24-000082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649824000082/avns-20241028.htm
  HTML page:      https://secwatch.observer/filing/0001606498-24-000082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer